[{"indications": "Indications\u00a0\n(From 8.1.1 Alkylating drugs: British National Formulary)\nTreosulfan is given by mouth or by intravenous or intraperitoneal administration and is used to treat ovarian cancer. Skin pigmentation is a common side-effect and allergic alveolitis, pulmonary fibrosis and haemorrhagic cystitis occur rarely.", "name": "TREOSULFAN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.1 Cytotoxic drugs", "8.1.1 Alkylating drugs"], "cautions": "Cautions\u00a0see section 8.1;\r\navoid in acute porphyria (but see section 9.8.2)", "side-effects": "Side-effects\u00a0see section 8.1 and notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4699.htm", "doses": ["Consult product literature"], "pregnancy": "Pregnancy\u00a0avoid; see also Pregnancy and Reproductive\r\nFunction"}]